In a study of patients with all subtypes of MS, antibodies specific to KIR4.1 (an ATP-sensitive inward rectifying potassium channel expressed found primarily on glial cells) were found in roughly half of the subjects. This evidence concerns the gene KCNJ10 and myeloid sarcoma.